logo
High Noon recalls vodka seltzer cans mislabeled as energy drinks

High Noon recalls vodka seltzer cans mislabeled as energy drinks

UPIa day ago
U.S. Food and Drug Administration
High Noon is recalling some of its vodka seltzer packs after finding that a few cans were incorrectly labeled as non-alcoholic energy drinks.
The U.S. Food and Drug Administration (FDA) said on Wednesday that two lots of the High Noon Beach Variety 12-pack contain cans labeled as "CELSIUS® ASTRO VIBE™ Energy Drink, Sparkling Blue Razz Edition."
But the cans still contain alcohol, not energy drink liquid.
"The recall was initiated after High Noon discovered that a shared packaging supplier mistakenly shipped empty CELSIUS cans to High Noon," the FDA said.
The mislabeled cans can be identified by a silver top, rather than the usual black top on Celsius drinks.
No one has gotten sick or reported health problems so far, but drinking alcohol by mistake could be dangerous - especially for people avoiding alcohol due to age, health or other reasons.
The recalled seltzer 12-packs were sent to distributors in: Florida, Michigan, New York, Ohio, Oklahoma, South Carolina, Virginia and Wisconsin.
Distributors shipped the product to retailers in Florida, New York, Ohio, South Carolina, Virginia and Wisconsin.
The recalled High Noon Beach Variety 12-packs have this UPC code: 085000040065.
Lot codes:
L CCC 17JL25 14:00 to L CCC 17JL25 23:59
L CCC 18JL25 00:00 to L CCC 18JL25 03:00
The mislabeled Celsius cans have this UPC code: 8 89392 00134 1.
Lot codes (found on the bottom of the can):
L CCB 02JL25 2:55 to L CCB 02JL25 3:11
Customers who find they have one of the mislabeled cans should not drink it.
Instead, they should throw it away and email consumerrelations@highnoonvodka.com to request a refund, the FDA said.
More information
Read the full recall notice at the U.S. Food and Drug Administration.
SOURCE: U.S. Food and Drug Administration, July 30, 2025
Copyright © 2025 HealthDay. All rights reserved.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Sam's Club freeze dried fruit recalled over possible Listeria contamination
Sam's Club freeze dried fruit recalled over possible Listeria contamination

The Hill

time32 minutes ago

  • The Hill

Sam's Club freeze dried fruit recalled over possible Listeria contamination

A recall has been issued for a popular dried fruit snack sold at Sam's Club amid concerns that the packages may be contaminated with Listeria. The snack is Member's Mark Freeze Dried Fruit Variety Pack 15-count. The U.S. Food and Drug Administration announced the recall by Doehler Dry Ingredient Solutions LLC, in a press release Thursday, noting that no illnesses had been reported yet from the possible Listeria monocytogenes exposure. According to the Food and Drug Administration (FDA), the contamination was discovered by the company during 'internal testing of their products.' The potentially affected products were distributed between July 1-25 and were sold at Sam's Club stores across the U.S. The FDA is advising people not to consume the snack if they purchased it during that window of time. Listeria monocytogenes can cause serious and sometimes fatal infections in young children, elderly people, and those with weakened immune systems. Exposure among healthy people can lead to symptoms like fevers, nausea and abdominal pain. Health officials warn that listeria can result in miscarriages and stillbirths among pregnant women.

MEDIA ADVISORY: Baycrest Experts Available During AAIC® 2025 in Toronto
MEDIA ADVISORY: Baycrest Experts Available During AAIC® 2025 in Toronto

Yahoo

timean hour ago

  • Yahoo

MEDIA ADVISORY: Baycrest Experts Available During AAIC® 2025 in Toronto

TORONTO, July 25, 2025 /CNW/ - From July 27 to 31, Toronto hosts the Alzheimer's Association International Conference® 2025 (AAIC®), the world's largest forum for dementia research. With Canada in the spotlight, Baycrest is recognized globally for its leadership in aging and brain health. Our scientists and experts are participating in the conference and available to support your coverage. This international gathering offers a timely opportunity to explore the growing impact of dementia on families, economies and health care systems, along with the latest advances in prevention, care, treatment and research. Dr. Howard ChertkowScientific Director, Baycrest's Kimel Family Centre for Brain Health & WellnessScientific Director, Canadian Consortium on Neurodegeneration in Aging (CCNA)Dr. Chertkow is a member of the AAIC Scientific Program Committee and one of Canada's most respected dementia researchers. He is available to speak on topics including dementia detection, prevention, treatment and Canada's role in the global research landscape. More Baycrest Experts You Can Speak With Dr. Adriana Shnall, Program Director, Baycrest Koschitzky Centre for Innovations in Caregiving, can speak to innovative tools supporting dementia caregivers, including those in rural and underserved communities. At AAIC, she is co-presenting on the use of virtual reality, AI and other strategies to better support families in community and long-term care settings. Dr. Allison Sekuler, President & Chief Scientist, Baycrest Academy for Research and Education is available to speak on the rising prevalence of dementia in Canada and its impact on individuals, families and the healthcare system. Dr. Nicole Anderson, Associate Scientific Director, Baycrest's Kimel Family Centre for Brain Health & Wellness, can discuss the latest in dementia prevention research, including evidence that nearly half of all cases may be preventable. Baycrest combines world-class care with cutting-edge research to help shape the future of aging and brain health. If you are working on AAIC-related coverage or broader dementia stories, our experts are available for interviews throughout the conference. Throughout the week, we will share updates with media highlighting key topics, research developments and expert perspectives from Baycrest. Please contact Natasha Nacevski-Laird, Media Relations Specialist at Baycrest, to schedule an interview. About Baycrest At Baycrest, our vision is a world where every older person lives with purpose, fulfilment and dignity. Baycrest is a global leader in aging and brain health innovation, with over 105 years of expertise in seniors' care and cutting-edge research. Baycrest has been Designated with Exemplary Status by Accreditation Canada, and drives industry-leading care and safety outcomes. As the home of the Centre for Aging + Brain Health Innovation (CABHI) powered by Baycrest, the Baycrest Academy for Research and Education (BARE) and the Canadian Consortium on Neurodegeneration in Aging, Baycrest is at the forefront of dementia research. Affiliated with the University of Toronto, Baycrest's training programs shape the future of care globally, while Baycrest Global Solutions extends its expertise to senior living and healthcare internationally. For more information, visit: SOURCE Baycrest View original content to download multimedia:

New at-home lab test gives postpartum mothers real answers—before the six-week checkup
New at-home lab test gives postpartum mothers real answers—before the six-week checkup

Yahoo

time2 hours ago

  • Yahoo

New at-home lab test gives postpartum mothers real answers—before the six-week checkup

A postpartum care revolution that finally puts moms first. America's postpartum experience is broken. By the time a mother finally sees her OB at six weeks postpartum, she's already endured some of the hardest weeks of her entire life with little medical oversight. In my case, after my first child was born I was in excruciating urethra pain that I thought was normal, because there was no doctor's visit to catch it. For other moms, postpartum depression plagues their first few weeks of motherhood. Other women experience the crisis of postpartum preeclampsia without medical oversight, trying to determine if their symptoms are normal or intervention-worthy. What if moms were screened far before a medical crisis occurs postpartum? That's the promise behind a new innovation from Trellis Health: the first FDA-cleared, at-home postpartum lab panel designed specifically to catch health issues before they spiral. Created by moms for moms, this tool fills a critical gap in maternal healthcare and provides medically actionable insights. Related: This new at-home program is redefining postpartum care for moms The postpartum data cliff is real—and dangerous Here's the current reality: Women receive rigorous testing throughout pregnancy. But once the baby arrives, all that data collection… disappears. According to the American College of Obstetricians and Gynecologists (ACOG), the first 40 days after giving birth are critical to a mother's long-term health—yet our system treats them like a footnote. Roughly 1 in 5 mothers will experience a postpartum mood disorder. Up to 10% will face thyroid dysfunction. Half of women with gestational diabetes will develop type 2 diabetes within five years. Yet many won't receive a single lab test between delivery and the standard six-week checkup. 'We test hundreds of biomarkers during pregnancy. Then we test nothing,' said Trellis Health co-founder and CEO Dr. Estelle Giraud. 'That's a healthcare failure.' A test designed for the way moms actually live For $239 (HSA/FSA eligible), the Trellis test offers a finger-to-fridge solution: a painless blood collection patch you stick to your upper arm. In ten minutes, it collects a sample to analyze more than 30 biomarkers—from thyroid function and hormone levels to inflammation and cardiovascular risk. Results arrive within 3–4 days and integrate directly into the Trellis app, which serves as a digital 'care in your pocket' with asynchronous midwife support and a full health timeline. 'Six weeks is a perfect moment to catch things like nutrient deficiencies before they spiral into fatigue, mood, and lactation issues,' Giraud said in an interview with The Bump. Related: Why nutrition is the missing piece in postpartum care Why this is a lifeline For moms managing naps, cluster feeds, and toddler tantrums, the idea of booking labs, securing childcare, and making it to a clinic is often laughable. And for those with limited healthcare access—rural families, single moms, uninsured patients—Trellis could be the only lab work they receive during this vulnerable window. 'I had gestational diabetes, and this was easier than my CGMand this is easier than my CGM [Continuous Glucose Monitoring]—the whole process was simple and so straightforward,' said beta tester Amara Bell. Experts urge thoughtful use—but recognize its potential Dr. Christine Greves, an OB-GYN at Orlando Health Women's Institute, told The Bump she's excited by the test's proactive potential, especially since over half of maternal deaths occur after delivery and most are preventable. But she also cautions that hormone levels in postpartum bodies are naturally in flux and that test results should always be interpreted in partnership with a trusted provider. In other words: Data is powerful—but it's still just a starting point. A test—and a message—that puts women in charge This test is a wake-up call for a healthcare system that treats birth like a finish line instead of a starting point. For too long, postpartum recovery has been framed as a private struggle. Moms are told to 'listen to their bodies' but given no tools to actually understand them. Trellis flips that script by putting clinical-grade insight into a mom's own hands. What you can do now: Bring this data to your six-week checkup: Ask about iron, thyroid, and vitamin D levels. Request follow-ups if anything feels off. If you're pregnant or postpartum you can pre-order the test at Financial hardship options are available; email support@ to apply. Advocate for systemic change: Paid leave, universal postpartum check-ins, and real investment in maternal health shouldn't be optional. Because 'just tired' should never be the answer when something deeper is going on. Sources: New At-Home Lab Test Closes Gap In Postpartum Care. 2025. Forbes. New At-Home Lab Test Closes Gap In Postpartum Care. First At-Home Postpartum Lab Test Aims to Empower Moms. 2025. The Bump. First At-Home Postpartum Lab Test Aims to Empower Moms. Postpartum risk for type 2 diabetes following gestational diabetes mellitus: A systematic review and meta-analysis. 2022. Preventing Chronic Disease (CDC). Postpartum risk for type 2 diabetes following gestational diabetes mellitus. Postpartum Thyroiditis: Diagnosis and Management. 2020. Endocrine Abstracts. Postpartum Thyroiditis. Maternal Mental Health Conditions and Statistics. 2025. Maternal Mental Health Leadership Alliance. Maternal Mental Health Conditions and Statistics. Optimizing Postpartum Care. 2018. American College of Obstetricians and Gynecologists. Optimizing Postpartum Care.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store